We suggest starting with a 1,000 mcg dose given weekly
Rather than relying on systemic distribution to deliver neuroprotective compounds to the brain, CAQK homes specifically to injured brain tissue when administered intravenously
Medicare Part B covers outpatient cancer treatment including chemotherapy administered in a doctors office, radiation therapy, targeted therapy drugs administered in an outpatient setting, and cancer screenings
Oral delivery is convenient for maintenance protocols with KPV or BPC-157
If you have a proven deficiency and want a professionally delivered top-up, we can help on an agreed plan
A research vial is not a therapy: AHK-Cu is not FDA-approved , is not comparable to evidence-based hair-loss treatments such as minoxidil or finasteride, and a grey-market vial has unverified identity, potency and purity